blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1560586

EP1560586 - THE USE OF AN ANTI-ALLERGY AGENT AND A STEROID TO TREAT ALLERGIC RHINITIS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  09.05.2008
Database last updated on 13.07.2024
Most recent event   Tooltip09.05.2008Application deemed to be withdrawnpublished on 11.06.2008  [2008/24]
Applicant(s)For all designated states
Alcon, Inc.
Bösch 69
6331 Hünenberg / CH
[2006/02]
Former [2005/32]For all designated states
Alcon, Inc.
Bosch 69, P.O. Box 62
6331 Hünenberg / CH
Inventor(s)01 / CAGLE, Gerald, D.
6309 Greenway
Fort Worth, TX 76116 / US
02 / WALL, G., Michael
4417 Ledgeview Road
Fort Worth, TX 76109 / US
03 / YANNI, John, M.
2821 Donnybrook Drive
Burleson, TX 76028 / US
04 / JANI, Rajni
4621 Briarhaven Road
Fort Worth, TX 76109 / US
05 / BHAGAT, Haresh, G.
6437 Elmcrest Court
Fort Worth, TX 76132 / US
 [2005/32]
Representative(s)Teipel, Stephan, et al
Lederer & Keller
Patentanwälte Partnerschaft mbB
Unsöldstrasse 2
80538 München / DE
[N/P]
Former [2005/32]Teipel, Stephan, Dr., et al
Lederer & Keller Patentanwälte Prinzregentenstrasse 16
80538 München / DE
Application number, filing date03768901.512.11.2003
[2005/32]
WO2003US36054
Priority number, dateUS20020425494P12.11.2002         Original published format: US 425494 P
[2005/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004043470
Date:27.05.2004
Language:EN
[2004/22]
Type: A1 Application with search report 
No.:EP1560586
Date:10.08.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 27.05.2004 takes the place of the publication of the European patent application.
[2005/32]
Search report(s)International search report - published on:EP27.05.2004
ClassificationIPC:A61K31/5513, A61K31/335, A61K31/575, A61K31/573, A61P27/14
[2005/32]
CPC:
A61K31/5513 (EP,KR,US); A61K31/335 (KR); A61K31/355 (EP,US);
A61K31/573 (EP,US); A61K31/575 (EP,US); A61K9/0043 (EP,US);
A61P11/02 (EP); A61P27/14 (EP); A61P37/08 (EP);
A61P43/00 (EP); A61P5/44 (EP) (-)
C-Set:
A61K31/355, A61K2300/00 (EP,US);
A61K31/5513, A61K2300/00 (US,EP);
A61K31/573, A61K2300/00 (US,EP);
A61K31/575, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/32]
TitleGerman:VERWENDUNG VON EINEM ANTIALLERGIKUMS UND EINEM STEROID ZUR BEHANDLUNG VON ALLERGISCHE RHINITIS[2005/32]
English:THE USE OF AN ANTI-ALLERGY AGENT AND A STEROID TO TREAT ALLERGIC RHINITIS[2005/32]
French:UTILISATION D'UN AGENT ANTI-ALLERGIQUE ET D'UN STEROIDE POUR TRAITER UNE RHINITE ALLERGIQUE[2005/32]
Entry into regional phase31.03.2005National basic fee paid 
31.03.2005Designation fee(s) paid 
31.03.2005Examination fee paid 
Examination procedure13.05.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
31.03.2005Examination requested  [2005/32]
21.12.2005Despatch of a communication from the examining division (Time limit: M04)
28.04.2006Reply to a communication from the examining division
23.05.2006Despatch of a communication from the examining division (Time limit: M06)
31.10.2006Reply to a communication from the examining division
06.12.2006Despatch of a communication from the examining division (Time limit: M04)
12.04.2007Reply to a communication from the examining division
06.08.2007Despatch of a communication from the examining division (Time limit: M04)
18.12.2007Application deemed to be withdrawn, date of legal effect  [2008/24]
18.01.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2008/24]
Fees paidRenewal fee
29.11.2005Renewal fee patent year 03
27.11.2006Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.11.200705   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]WO0135963  (ALCON UNIVERSAL LTD [CH], et al) [X] 1-10 * example -; claim - * [Y] 1-10;
 [YD]WO9701337  (MCNEIL PPC INC [US]) [YD] 1-10 * abstract *;
 [PX]WO03049770  (ALCON INC [CH], et al) [PX] 1-10 * abstract *
 [XY]  - LANIER BOB Q ET AL, "Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge.", CLINICAL THERAPEUTICS. JUL 2002, (200207), vol. 24, no. 7, ISSN 0149-2918, pages 1161 - 1174, XP002274753 [X] 1-10 * abstract * [Y] 1-10

DOI:   http://dx.doi.org/10.1016/S0149-2918(02)80027-3
ExaminationWO9746243
    - DAY AND CARILLO, "COMPARISON OF THE EFFICACY OF BUDESONIDE AND FLUTICASONE PROPIONATE AQUEOUS NASAL SPRAY FOR ONCE DAILY TREATMENT OF PERENNIAL ALLERGIC RHINITIS", J ALLERGY CLIN IMMUNOL, (199812), pages 902 - 908, XP005686898

DOI:   http://dx.doi.org/10.1016/S0091-6749(98)70326-4
    - NAYAK ET AL, "INTRANASAL FLUTICASONE PROPIONATE (FP) IS MORE EFFECTIVE THAN LORATADINE (LOR) FOR TREATMENT OF SEASONAL ALLERGIC RHINITIS", J ALLERGY CLIN IMMUNOL, (199601), page 198, XP005581600

DOI:   http://dx.doi.org/10.1016/S0091-6749(96)80281-8
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.